Hims & Hers (HIMS) Stock Rally Meets Margin Pressure And GAAP Loss The story with Hims & Hers Health today is the gap between the selloff and the scoreboard. The stock slipped…
Hims & Hers planning to sell compounded peptides Hims & Hers Health is planning to sell compounded peptides, the company said in a Monday earnings call. The company’s…
Hims & Hers posts $753M in Q2 revenue as it preps for push into peptide market Digital health and wellness company Hims & Hers is ready to tap into a multi-billion peptide market if U.S. regulators…
FTC Continues Investigation into Hims & Hers Health, Inc. as Lowey Dannenberg Files Class Action Complaint on Behalf of Consumers Lowey Dannenberg announces that it filed a class action complaint against Hims & Hers Health, Inc. on behalf of consumers…
Is Hims & Hers Health (HIMS) Undervalued After Its Q2 2026 Loss? Hims & Hers Health (HIMS) is back in focus after its second quarter 2026 earnings, which showed US$753.2 million in…
Bank of America Forecasts Strong Price Appreciation for Hims & Hers Health (NYSE:HIMS) Stock Bank of America boosted their price objective on Hims & Hers Health from $30.00 to $32.00 and gave the company…
Will Hims & Hers’ Higher 2026 Revenue Guidance Amid Rising Losses Change HIMS’s Investment Narrative? Hims & Hers Health, Inc. reported second-quarter 2026 sales of US$753.21 million, up from US$544.83 million a year earlier, but…
Hims & Hers – Der US-Telemedizinanbieter hebt die Prognose an und fällt trotzdem! Hims hebt die Umsatzprognose kräftig an – und die Aktie fällt trotzdem. Schuld ist ein Verlust von 37 statt erwarteter…
Hims & Hers Health (NYSE:HIMS) Shares Gap Down Hims & Hers Health (NYSE:HIMS) Shares Gap Down - Heres Why…
Hims & Hers Stock (HIMS) Slides as GLP-1 Push Swallows Profits and Widens Q2 Loss Shares of Hims Hers Health ($HIMS), a U.S. telehealth firm, fell over 7% in premarket trading on Tuesday after…